The Obesity Paradox in Cancer: a Review

Current Oncology Reports

Volumn 18, Issue 9, 2016, Pages

  Lennon, Hannah ^a   Sperrin, Matthew ^a   Badrick, Ellena ^a   Renehan, Andrew G ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Adiposity; BMI; Body mass index; Cancer; Cancer survival; Epidemiology; Excess weight; Mortality; Obesity; Overweight; Prognosis

Indexed keywords

BODY MASS; BODY WEIGHT; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; COLLIDER STRATIFICATION BIAS; DETECTION BIAS; HUMAN; MORTALITY; NEOPLASM; OBESITY; REVIEW; SELECTION BIAS; STATISTICAL CONCEPTS; COMPLICATION; NEOPLASMS; OVERWEIGHT; PATHOLOGY; PHYSIOLOGY; RISK FACTOR; SURVIVAL RATE;

ADIPOSITY; BODY MASS INDEX; HUMANS; NEOPLASMS; OBESITY; OVERWEIGHT; RISK FACTORS; SURVIVAL RATE;

EID: 84981156268     PISSN: 15233790     EISSN: 15346269     Source Type: Journal    
DOI: 10.1007/s11912-016-0539-4     Document Type: Review

References (49)

1. WHO. GHO|By category|Overweight (body mass index > = 25) (age-standardized estimate)—data by country [Accessed 18 March 2016].
2. WCRF A. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. World Cancer Research Fund and American Institute For Cancer Research. 2nd ed. Washington: American Institute for Cancer Research; 2007.
3. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569–78.
4. Chan DS, Vieira AR, Aune D, Bandera EV, Greenwood DC, McTiernan A, et al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol. 2014;25(10):1901–14.
5. Ligibel JA, Alfano CM, Courneya KS, Demark-Wahnefried W, Burger RA, Chlebowski RT, et al. American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol. 2014;32(31):3568–74.
6. Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012;62(4):243–74.
7. Senkus E, Kyriakides S, Penault-Llorca F, Poortmans P, Thompson A, Zackrisson S, et al. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24 Suppl 6:vi7–vi23.
8. Hines RB, Shanmugam C, Waterbor JW, McGwin G, Funkhouser E, Coffey CS, et al. Effect of comorbidity and body mass index on the survival of African-American and Caucasian patients with colon cancer. Cancer. 2009;115:5798–806.
9. Navarro WH, Loberiza Jr FR, Bajorunaite R, van Besien K, Vose JM, Lazarus HM, et al. Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2006;12:541–51.
10. Parker AS, Lohse CM, Cheville JC, Thiel DD, Leibovich BC, Blute ML. Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma. Urology. 2006;68:741–6.
11. Schlesinger S, Siegert S, Koch M, Walter J, Heits N, Hinz S, et al. Postdiagnosis body mass index and risk of mortality in colorectal cancer survivors: a prospective study and meta-analysis. Cancer Causes Control. 2014;25:1407–18.
12. Hakimi AA, Furberg H, Zabor EC, Jacobsen A, Schultz N, Ciriello G, et al. An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma. J Natl Cancer Inst. 2013;105:1862–70.
13. Amptoulach S, Gross G, Kalaitzakis E. Differential impact of obesity and diabetes mellitus on survival after liver resection for colorectal cancer metastases. J Surg Res. 2015;199:378–85.
14. Brunner AM, Sadrzadeh H, Feng Y, Drapkin BJ, Ballen KK, Attar EC, et al. Association between baseline body mass index (BMI) and overall survival among patients over age 60 with acute myeloid leukemia (AML). Am J Hematol. 2013;88:642–6.
15. Tsang NM, Pai PC, Chuang CC, Chuang WC, Tseng CK, Chang KP, et al. Overweight and obesity predict better overall survival rates in cancer patients with distant metastases. Cancer Med 2016:n/a-n/a.
16. Banack HR, Kaufman JS. The obesity paradox: understanding the effect of obesity on mortality among individuals with cardiovascular disease. Prev Med. 2014;62:96–102.
17. Doehner W, Haehling SV, Anker SD. Protective overweight in cardiovascular disease: moving from ‘paradox’ to ‘paradigm’. Eur Heart J 2015:ehv414.
18. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53:1925–32.
19. McAuley PA, Artero EG, Sui X, Lee D-c, Church TS, Lavie CJ, et al. The obesity paradox, cardiorespiratory fitness, and coronary heart disease. Mayo Clin Proc. 2012;87:443–51.
20. McAuley PA, Blair SN. Obesity paradoxes. J Sports Sci. 2011;29:773–82.
21. Tobias DK, Pan A, Jackson CL, O’Reilly EJ, Ding EL, Willett WC, et al. Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med. 2014;370(3):233–44.
22. Arnold M, Leitzmann M, Freisling H, Bray F, Romieu I, Renehan A, et al. Obesity and cancer: an update of the global impact. Cancer Epidemiol. 2016;41:8–15.
23. Daniel CR, Shu X, Ye Y, Gu J, Raju GS, Kopetz S, et al. Severe obesity prior to diagnosis limits survival in colorectal cancer patients evaluated at a large cancer centre. Br J Cancer. 2016;114:103–9.
24. Crosbie EJ, Roberts C, Qian W, Swart AM, Kitchener HC, Renehan AG. Body mass index does not influence post-treatment survival in early stage endometrial cancer: results from the MRC ASTEC trial. Eur J Cancer. 2012;48:853–64.
25. Yoon HH, Lewis MA, Shi Q, Khan M, Cassivi SD, Diasio RB, et al. Prognostic impact of body mass index stratified by smoking status in patients with esophageal adenocarcinoma. J Clin Oncol. 2011;29:4561–7.
26. Zhang S, Folsom AR, Sellers TA, Kushi LH, Potter JD. Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. The Iowa Women’s Health Study. Cancer. 1995;76:275–83.
27. Feng Y-H. The association between obesity and gynecological cancer. Gynecol Minim Invasive Ther. 2015;4:102–5.
28. Parekh N, Chandran U, Bandera EV. Obesity in cancer survival. Annu Rev Nutr. 2012;32:311–42.
29. Parkin E, O’Reilly DA, Sherlock DJ, Manoharan P, Renehan AG. Excess adiposity and survival in patients with colorectal cancer: a systematic review. Obes Rev. 2014;15:434–51.
30. Wu S, Liu J, Wang X, Li M, Gan Y, Tang Y. Association of obesity and overweight with overall survival in colorectal cancer patients: a meta-analysis of 29 studies. Cancer Causes Control. 2014;25:1489–502.
31. WCRF. World Cancer Research Fund International. Continuous Update Project Report: diet, nutrition, physical activity, and breast cancer survivors. 2014. Available at:www.wcrf.org/sites/default/files/Breast-Cancer-Survivors-2014-Report.pdf [Accessed 20th Dec 2014]. 2014.
32. Reichle K, Peter RS, Concin H, Nagel G. Associations of pre-diagnostic body mass index with overall and cancer-specific mortality in a large Austrian cohort. Cancer Causes Control. 2015;26:1643–52.
33. Navarro WH, Agovi M-A, Logan BR, Ballen K, Bolwell BJ, Frangoul H, et al. Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults. Biol Blood Marrow Transplant. 2010;16:1442–50.
34. Coe PO, O’Reilly DA, Renehan AG. Excess adiposity and gastrointestinal cancer. Br J Surg. 2014;101(12):1518–31. discussion 1531.
35. Shuster A, Patlas M, Pinthus JH, Mourtzakis M. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol. 2012;85(1009):1–10.
36. Gonzalez MC, Pastore CA, Orlandi SP, Heymsfield SB. Obesity paradox in cancer: new insights provided by body composition. Am J Clin Nutr. 2014;99(5):999–1005.
37. Stokes A, Preston SH. Revealing the burden of obesity using weight histories. Proc Natl Acad Sci U S A. 2016;113:572–7.
38. Banack HR, Kaufman JS. From bad to worse: collider stratification amplifies confounding bias in the “obesity paradox”. Eur J Epidemiol. 2015;30(10):1111–4. A prospective cohort study of 15,792 US men and women showing that confounding bias increases in the presence of collider stratification bias.
39. Sperrin M, Candlish J, Badrick E, Renehan A, Buchan I. Collider bias cannot explain most of the obesity paradox [in press]. Epidemiology 2016. A simulation study that collider bias is an infrequent cause of the obesity paradox.
40. Johnson JA, Bowker SL, Richardson K, Marra CA. Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias. Diabetologia. 2011;54:2263–71.
41. Renehan AG, Crosbie EJ, Campbell PT. Re: Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients. J Natl Cancer Inst. 2014;106(2):djt375.
42. Gelber RP, Kurth T, Manson JE, Buring JE, Gaziano JM. Body mass index and mortality in men: evaluating the shape of the association. Int J Obes. 2007;31:1240–7. 200.
43. Tseng C-H. Obesity paradox: differential effects on cancer and noncancer mortality in patients with type 2 diabetes mellitus. Atherosclerosis. 2013;226:186–92.
44. Renehan AG, Flood A, Adams KF, Olden M, Hollenbeck AR, Cross AJ, et al. Body mass index at different adult ages, weight change, and colorectal cancer risk in the National Institutes of Health-AARP Cohort. Am J Epidemiol. 2012;176:1130–40.
45. Nagle CM, Dixon SC, Jensen A, Kjaer SK, Modugno F, DeFazio A, et al. Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium. Br J Cancer. 2015;113:817–26.
46. Wong AL, Seng KY, Ong EM, Wang LZ, Oscar H, Cordero MT, et al. Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients. Breast Cancer Res Treat. 2014;144:143–52.
47. Gurunathan U, Myles PS. Limitations of body mass index as an obesity measure of perioperative risk. Br J Anaesth. 2016;116:319–21.
48. Sinicrope FA, Foster NR, Yothers G, Benson A, Seitz JF, Labianca R, et al. Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy. Cancer. 2013;119(8):1528–36.
49. Demark-Wahnefried W, Platz EA, Ligibel JA, Blair CK, Courneya KS, Meyerhardt JA, et al. The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomark Prev. 2012;21:1244–59.